Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive.

Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive.

Item
http://www.wikidata.org/entity/Q37894095
Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients.Axl as a mediator of cellular growth and survivalUSP8 is a novel target for overcoming gefitinib resistance in lung cancer.Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer.Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors.Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy.Beyond platinum treatment for NSCLC: what does the future hold?Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients.Second-line therapy of squamous non-small cell lung cancer: an evolving landscape.5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer.Liquid biopsy for lung cancer early detection.Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors.
P2860

Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive.

Item
http://www.wikidata.org/entity/Q37894095
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tyrosine kinase inhibitors for ...... tients who will be responsive.
@en
Tyrosine kinase inhibitors for ...... tients who will be responsive.
@nl
type
label
Tyrosine kinase inhibitors for ...... tients who will be responsive.
@en
Tyrosine kinase inhibitors for ...... tients who will be responsive.
@nl
prefLabel
Tyrosine kinase inhibitors for ...... tients who will be responsive.
@en
Tyrosine kinase inhibitors for ...... tients who will be responsive.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Tyrosine kinase inhibitors for ...... tients who will be responsive.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698